Dr. Michael Fischbach

Biography

Michael Fischbach is the Liu (Liao) Family Professor in the Department of Bioengineering at Stanford University and serves as the director of the Stanford Microbiome Therapies Initiative. He is an Institute Scholar at Stanford ChEM-H and has made significant contributions to understanding microbiome-host interactions. Fischbach's academic accolades include the NIH Director's Pioneer New Innovator Award and the HHMI-Simons Faculty Scholars Award. He has also been recognized with fellowships from the David and Lucile Packard Foundation and the W.M. Keck Foundation. Fischbach’s research focuses on the mechanisms of pathogenesis concerning infectious diseases, particularly in relation to bacterial iron acquisition and the biosynthesis of antibiotics. After obtaining his Ph.D. from Harvard University in 2007, he was a postdoctoral fellow at Massachusetts General Hospital before joining the faculty at UCSF and eventually moving to Stanford in 2017. In addition to his academic roles, Fischbach is a co-founder of Revolution Medicines and Kelonia, and serves on the scientific advisory boards of various initiatives, including the Chan Zuckerberg Initiative and Stand Cancer.

Research Interests